The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, November 15, 2024
AlveoGene announced the company has been granted a Rare Pediatric Disease Designation (RPDD) by the FDA for AVG-002, its novel inhaled gene therapy ...
read more
Thursday, November 14, 2024
The FDA approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and...
read more
Wednesday, November 13, 2024
BioNTech SE announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the ...
read more
Wednesday, November 13, 2024
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published an action plan for increasing flexibility of antibody...
read more
Tuesday, November 12, 2024
BrainStorm Cell Therapeutics Inc. has entered into a Memorandum of Understanding (MOU) with Pluri Inc. to manufacture NurOwn® for use in BrainStorm's ...
read more
Wednesday, October 30, 2024
Revitope Oncology Inc. announced that it has signed a license agreement providing Genmab A/S (Genmab) access to Revitope's conditional TCE technology,...
read more
Wednesday, October 23, 2024
Lonza announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. The...
read more
Wednesday, October 23, 2024
Cryoport, Inc. and Gulf Coast Regional Blood Center, a non-profit community blood center serving more than 26 counties throughout the state of Texas, ...
read more
Tuesday, October 22, 2024
Editas Medicine, Inc. and Genevant Sciences announced that they have entered into a collaboration and nonexclusive license agreement to combine Editas...
read more
The FDA has approved zolbetuximab-clzb (Vyloy, Astellas Pharma US, Inc.), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, with fluoropyrimidine...
read more
OmniaBio Inc. announced the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of ...
read more
Wednesday, October 16, 2024
The investigational product, TVGN 920, will be manufactured utilizing Tevogen’s proprietary ExacTcell™ technology, in which genetically unmodified, ...
read more
Tuesday, October 08, 2024
AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance the development of an early stage, ...
read more
Tuesday, October 08, 2024
GBI Biomanufacturing, a Contract Development and Manufacturing Organization (CDMO), and Allterum Therapeutics announced a manufacturing partnership to...
read more
Tuesday, October 08, 2024
Dark Horse Consulting Group, the longstanding global leader in strategic and operational consulting in the field of cell and gene therapy, is ...
read more